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r e s o u r c e Long non-coding RNAs (lncRNAs) constitute a key component of the repertoire of regulatory elements that control cell differentiation 1 . However, the lncRNA 'landscape' of human lymphoid commitment is unknown; thus, knowledge of the transcriptional programs that launch human lymphopoiesis and regulate the subsequent fate 'decision' between the T cell lineage and B cell lineage is incomplete. We assembled a lncRNA catalog through whole-transcriptome sequencing of rare hematopoietic stem cell (HSC) and lymphoid progenitor cell populations that encompassed the earliest stages of commitment to the B lineage and T lineage in the human bone marrow (BM) and thymus.
HSCs and lymphoid progenitor cells in both the BM and the thymus express the surface antigen CD34 (refs. 2,3). Although various immunophenotypic subsets of CD34 + progenitor cells have been identified, the exact developmental relationships among these populations remain undefined. In particular, the identity of the dominant BM progenitor cell that migrates to the human thymus and initiates T cell differentiation has remained obscure due to the inherent limitations of functional assays of human progenitor cells. Expression of the surface antigen CD10 has long been used to define the so-called 'common lymphoid progenitors' (CLPs), which have been thought to represent the first stage of human lymphoid commitment in the BM and cord blood because of their broad ability to generate all lymphoid lineages 2 . The CD10 + progenitor cells have also been postulated to be the BM-derived precursor cells that seed the thymus, because of their ability to generate T cells in culture 2,4,5 . A lymphoid progenitor population that lacks CD10 expression but nonetheless has robust B cell, T cell and natural killer (NK) cell potential has been identified; these CD34 + CD38 + CD45RA + CD10 − CD62L hi lineage markernegative (Lin − ) cells were called 'lymphoid-primed multipotent progenitors' (LMPPs) because of functional similarity to the previously described Flt3 + mouse LMPPs, which lack erythroid and megakaryocytic potential 6 .
Commitment to the B lymphoid lineage begins in the BM; coexpression of the signal-transduction receptor CD19 and CD34 on the cell surface defines a fully B cell-committed progenitor (BCP) that lacks the potential to develop into any other lymphoid lineage (NK cell or T cell) 7 . Commitment to the T lymphoid lineage is initiated by the arrival of BM-derived precursor cells in the thymus. CD34 + thymic progenitor cells constitute <1% of all thymocytes 8 and can be further fractionated on the basis of expression of the lymphoid marker CD7 and the antigen-presenting molecule CD1a 8, 9 . Two progenitor cell populations in the thymus with both lymphoid and myeloid potential have been described: CD34 + CD7 − CD1a − progenitor cells (~5% of CD34 + thymocytes), and CD34 + CD7 + CD1a − progenitor cells (~30-50% of CD34 + thymocytes) 8, 9 . The degree of myeloid potential varies between these two progenitor populations, and the developmental relationship between them is unknown 8, 9 . Upregulation of CD1a expression marks the third thymic progenitor population: the CD34 + CD7 + CD1a + cells that represent the earliest fully T lineage-committed progenitor stage 9 . These last cells generate CD4 + CD8 + (double-positive) thymocytes, which constitute the predominant population in the thymus, and further differentiate into single-positive (CD4 + or CD8 + ) T cells that egress from the thymus to be mature peripheral T lymphocytes 3, 9 .
We found here that the transcriptional repertoire of lymphoid progenitor cells in the BM and thymus, and the HSCs from which they were generated, constituted at least 9,400 genes encoding lncRNAs ('lncRNA genes'), over one third of which represented previously undiscovered genes. Sample-clustering analysis and Bayesian polytomous model selection revealed distinct global lncRNA expression patterns that corresponded to early commitment to lymphoid lineages or lineage specification (B cell or T cell). Global lncRNA expression patterns independently revealed developmental relationships among progenitor cells in the BM and thymus, which supported the conclusions that uncommitted thymic progenitor cells arise directly from BM-derived HSCs and/or LMPPs, while CD10 + CLPs and subsequent B cell differentiation proceed through a separate pathway, and that CD34 + CD7 − CD1a − progenitor cells represent the earliest developmental stage of thymopoiesis. Our data constitute a resource for the elucidation of lncRNA mechanisms that regulate the earliest stages of human lymphopoiesis.
RESULTS lncRNAs newly identified in HSCs and lymphoid progenitor cells
To annotate previously unknown lncRNAs during the commitment of human cells to lymphoid lineages, we performed whole-transcriptome sequencing (RNA-Seq) of RNA from ten distinct cell types isolated by flow cytometry. From the BM, we isolated CD34 + CD38 − Lin − cells, a population with considerable enrichment for HSCs, as well as three lymphoid progenitor populations: LMPPs, CLPs (CD34 + CD38 + CD10 + CD45RA + Lin − ) and BCPs (CD34 + CD38 + CD19 + ). From the thymus we isolated three CD34 + CD4 − CD8 − subsets, Thy1 (CD34 + CD7 − CD1a − ), Thy2 (CD34 + CD7 + CD1a − ) and Thy3 (CD34 + CD7 + CD1a + ), as well as fully T cell-committed populations, CD4 + CD8 + (Thy4), CD3 + CD4 + CD8 − (Thy5) and CD3 + CD4 − CD8 + (Thy6) (Fig. 1a and Supplementary  Fig. 1a,b) . We assembled the transcriptome by aligning and pooling reads from 20 samples (n = 2 biological replicates per cell type) to identify individual transcripts. The expression patterns of proteincoding genes known to be expressed specifically in hematopoietic stem-progenitor cells (HSPCs) or lymphoid lineages (B lineage, T lineage or both) (Supplementary Fig. 1c) were consistent with published studies 7, [10] [11] [12] , which confirmed the validity of our isolation and sequencing methods. lncRNAs were identified by an 'ab initio' assembly pipeline (Fig. 1b) . The final lncRNA annotation (Supplementary Table 1 ) used throughout was composed of long (>200-base pair) spliced transcripts with no sense exonic overlap with protein-coding genes. Analysis by CPAT ('coding potential-assessment tool') 13 and PhlyoCSF ('phylogenetic modeling of codon substitution frequencies') 14 , confirmed that these transcripts were largely devoid of protein-coding potential (Supplementary Fig. 1d ). This comprehensive annotation comprised a total of 18,268 lncRNA genes, with 3,880 previously unknown lncRNA genes not annotated in existing lncRNA databases 15, 16 (Supplementary Table 1 
previously unknown lncRNA transcripts were detected, of which 4,661 were transcribed from previously unannotated loci, while 2,190 represented previously unknown isoforms generated from previously annotated loci (Supplementary Table 1) . Using unique whole-genome alignment of our RNA-Seq libraries to estimate expression levels for genes in the final merged annotation (protein-coding genes and lncRNA genes), we found that a total of 9,444 lncRNA genes, of which 3,348 were previously unknown, were expressed at an FKPM ('fragments per kilobase of exon per million reads mapped') value of >1 in at least one sample (geneexpression estimates, GEO accession code GSE69239; Fig. 1c) . We also quantified the genes expressed in each cell type (Supplementary Table 2 ). Consistent with the strong correlation of gene expression between replicate samples (mean correlation coefficient = 0.95 (s.d. = 0.02); Supplementary Fig. 2a ), 80% (2,688 of 3,348) of novel lncRNA genes were expressed (FPKM > 1) in both replicates of at least one cell type. To confirm the validity of the RNA-Seq expression data, we assessed a subset of B cell-specific lncRNAs by quantitative PCR (n = 2 biological replicates per cell type, including a replicate that was separate from the samples used for RNA-Seq). We observed high concordance between expression results for quantitative PCR and those for RNA-Seq across the ten cell types for each of these genes (mean correlation = 0.92 (s.d. = 0.07); Supplementary Fig. 2b ).
Among the newly identified lncRNA genes expressed at an FKPM value of >1 in at least one sample, 2,652 were intergenic, while 696 flanked a protein-coding gene in a divergent orientation (overlapping with a protein-coding gene on the antisense strand) (data not shown). The size distribution of the newly identified lncRNA transcripts was similar to that of previously annotated lncRNAs 15, 16 ( Supplementary  Fig. 2c ). Of note, the newly identified lncRNA transcripts, regardless of whether they were transcribed from previously unnannotated loci or from annotated loci, had more abundant expression in these hematopoietic populations than that of previously annotated lncRNAs ( Fig. 1d and Supplementary Fig. 2d ). Analysis of RNA-Seq data from the Human Body Map Project (GEO accession code GSE30611; Supplementary Table 3) revealed that the lncRNA genes newly identified from our data were highly specific to the HSC and/or lymphoid populations we studied here (Fig. 1e) . Notably, among the 3,109 newly identified lncRNA genes expressed in the six thymic populations, less than one third overlapped a published catalog of lncRNAs derived from the transcriptional profiles of unfractionated thymocytes and T cell acute lymphoblastic leukemia cells 17 .
To further characterize the lncRNA expression signature obtained from our RNA-Seq analysis, we analyzed the transcription start sites (TSSs) of the newly identified lncRNA genes for the presence of histone modifications. Actively transcribed lncRNA genes have been shown to be associated with, among others, promoter-associated histone modification (trimethylation of histone 3 at Lys4 (H3K4me3)) or enhancer-associated histone modification (monomethylation of histone 3 at Lys4 (H3K4me1)) 18, 19 . Although it has been shown that histone modifications are regulated during differentiation, only a fraction of these are subjected to substantial dynamic changes 20 . Therefore, as low cell numbers rendered analysis of the rare populations used in this study by chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) largely unfeasible, we used publically available H3K4me1 and H3K4me3 ChIP-Seq data for hematopoietic progenitor (CD34 + ) and lymphoid cell populations 21 (Supplementary Table 3 ). In addition, we downloaded and re-analyzed RNA-Seq libraries for these same populations to identify the populations that were transcriptionally similar to the specific progenitor cells used to generate our RNA-Seq data set (Supplementary Fig. 3 ). We thus chose ChIP-Seq data from three populations for analysis: whole thymic tissue, CD19 + primary B lymphocytes, and mobilized peripheral blood HSPCs (defined as either CD34 + or CD133 + ) (Supplementary Table 3) .
Over one third of the TSSs of the newly identified lncRNA genes (37%) showed overlap with significant peaks (Supplementary Methods and Supplementary Table 4) for at least one type of histone modification, a proportion similar to that of previously annotated lncRNA genes associated with such histone modifications (37.5%), as well as that reported in a published analysis of epigenetic modifications 22 . H3K4me1 modifications showed a distribution of broader density around TSSs than did H3K4me3 modifications (Fig. 2a,b) . The TSSs of protein-coding genes tended to show high density of H3K4me3 modifications (low ratio of H3K4me1 to H3K4me3) in HSPCs and lymphoid cells (Fig. 2c , data for individual TSSs, Supplementary Table 4), a feature commonly associated with promoter regions. On the other hand, lncRNA TSSs tended to show a high ratio of H3K4me1 to H3K4me3 (Fig. 2c , data for individual TSSs, Supplementary Table 4), a feature commonly associated with enhancer regions 18, 19 .
In the case of protein-coding genes, transcripts with high expression were associated with a higher level of histone modification than that associated with transcripts that were not expressed or a set of randomly chosen transcripts (Fig. 2d) . In contrast, in the case of lncRNA genes, cell type-specific transcripts were associated with the highest density of histone modification (Fig. 2d) . In summary, our results indicated that the transcriptional 'landscapes' of human HSCs and lymphoid progenitor cells were characterized by numerous previously undescribed lncRNAs that were unique to these cell types.
Correlation of lncRNA gene expression and coding gene expression
To investigate co-expression patterns of lncRNA genes and proteincoding genes during lymphoid differentiation, we computed pairwise expression correlations between genes across all RNA-Seq samples. We first analyzed trans correlations of expression (defined as pairs consisting of genes separated by a distance of >1 megabase, or located on different chromosomes). The expression of lncRNA genes tended to be more positively correlated than negatively correlated with protein-coding genes in trans (4.0% of the pairs had a Spearman correlation coefficient |rho| (r s ) of >0.5, versus 2.7% with an r s of < −0.05, of a total of 215 × 10 6 trans correlations tested; Supplementary Table 5) . Consistent with published reports 2 , we observed the same tendency toward positive correlation for protein-coding gene-protein-coding gene pairs in trans (Supplementary Table 5 ). In all cases, the bias toward positive correlations was significantly higher than that obtained for a control set of trans correlations in which the expression of protein-coding genes was randomly 'shuffled' (Fig. 3a) .
We then analyzed cis correlations of expression (defined as pairs consisting of genes located within a genomic window of 100 kilobases). We found a higher proportion of positive correlations among cis correlations than among trans correlations, for both lncRNA geneprotein-coding gene pairs and protein-coding gene-protein-coding gene pairs (13.3% and 15.0%, respectively, for cis, versus 4.0% and 7.3%, respectively, for trans, with an r s value of >0.5; Supplementary Table 5 ). In all sets of gene pairs (protein-coding gene-protein-coding gene, protein-coding gene-lncRNA gene, and protein-coding genenewly identified lncRNA gene), positive cis correlations were higher than those obtained for random controls, but negative cis correlations were not (Fig. 3a) . We found the greatest proportion of positive and extremely positive correlations when we restricted the analysis to newly identified lncRNA genes (Supplementary Table 5) .
Gene-ontology analysis of protein-coding genes with strong positive cis correlations with lncRNA genes revealed enrichment for genes r e s o u r c e encoding products involved in the regulation of lymphocyte development and proliferation, hematopoiesis and immunological processes, relative to their abundance in the whole genome (Fig. 3b) . In contrast, genes with negative cis correlations were not significantly associated with these functional annotations (Fig. 3b) .
To gain further insight into the co-expression signature of genes under strong transcriptional regulation, we delineated the expression profiles of 6,793 genes (protein-coding and lncRNA genes) that were expressed differentially in at least one pairwise comparison of the ten cell types (a change in expression of over twofold and a false-discovery Distance from TSS Distance from TSS Distance from TSS Distance from TSS 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 -2,000 2,000 0 Supplementary Fig. 3 ), stratified by gene expression (key): high expression indicates the top 2,000 transcripts among all transcripts ranked by expression in that cell type; cell type-specific transcripts indicates those with peak expression in that cell type (exceeds twice the mean of the expression in all other cell types). Publically available ChIP-Seq data sets (Supplementary Table 3 ) were used for analysis of histone profiles. 23 to obtain twenty non-redundant expression profiles (Profiles 1-20), which we classified into seven broad groups (Groups I-VII; Fig. 3c and Supplementary Table 6 ). Four specific profiles showed significant enrichment for lncRNA genes (P < 0.05) compared with the proportion of lncRNA genes among all differentially expressed genes: those that peaked in expression with B lineage commitment (Profile 7); those that peaked in expression at the Thy3 stage of T cell commitment (Profile 13); and those that were upregulated in both B lymphoid populations and T lymphoid populations relative to their expression in HSCs (Profiles 14 and 15). The differentially expressed lncRNA genes showed significant enrichment (P < 0.05; relative to all lncRNA genes) for loci that neighbored protein-coding genes whose products were involved Moreover, lncRNA genes with cell type-specific expression patterns showed enrichment for loci that neighbored protein-coding genes with similar cell type specificity ( Supplementary Fig. 4 ). For example, HSPC (Group I) lncRNA genes showed enrichment for loci that neighbored HSPC-specific protein-coding genes. In summary, global co-expression analysis and gene-expression profiling suggested a notable and previously unappreciated role for lncRNAs in the lymphoid commitment of HSCs and in T cell and B cell specification.
lncRNA-based classification of BM and thymic progenitor cells
We next used sample clustering of transcriptomes to investigate developmental relationships among lymphoid progenitor cells in the BM and thymus. We clustered samples on the basis of genes (both proteincoding and lncRNA genes) that were expressed differentially in at least one pairwise comparison of the ten cell types (Tree 1, Fig. 4a ). CD34 + thymic progenitor cells (Thy1, Thy2 and Thy3) segregated with all four CD34 + populations in the BM (HSCs, LMPPs, CLPs and BCPs) rather than late (CD34 − ) thymic populations (Thy4, Thy5 and Thy6) (Fig. 4a) . Moreover, within the branch containing CD34 + progenitor cells, early thymic progenitor cells (Thy 1 and Thy 2) sub-clustered with HSCs and LMPPs, while CLPs and BCPs formed a separate group (Fig. 4a) . This phylogeny of samples was not affected by variations in the criteria used for gene selection (false-discovery rate and change in expression (fold)) or the inclusion of publically available RNA-Seq data sets for a wide range of tissues (Supplementary Methods and Supplementary Fig. 5a,b) , which indicated the robustness and validity of this clustering approach. We next constructed sample trees on the basis of differentially expressed genes from the following classes: Tree 2, protein-coding genes (Fig. 4b) ; Tree 3, all lncRNA genes (newly identified and previously annotated lncRNAs) (Fig. 4c) ; and Tree 4, newly identified lncRNA genes (Fig. 4d) . Of note, the clustering of B lineage-skewed progenitor cells (CLPs and BCPs) varied among the trees, whereas CD34 + thymic progenitor cells (Thy1, Thy2 and Thy3) clustered with HSCs and LMPPs in all four trees (Fig. 4) . The expression profiles of protein-coding genes clustered CLPs and BCPs with the other CD34 + cells in the BM (HSCs and LMPPs) and the thymus (Thy1, Thy2 and Thy3) (Fig. 4) . In contrast, the expression profiles of lncRNA genes (Tree 3 and Tree 4) segregated B lineage-skewed cells in a cluster distinct from all thymic populations (Thy1-Thy6) (Fig. 4c,d) , which indicated that the lncRNAs were expressed in a highly lineage-specific manner (B lineage versus T lineage). We generated the trees (Fig. 4) with randomly selected sets of differentially expressed genes (same set size and similar overall gene expression levels for all sets), which indicated that the differences between protein-coding gene trees and lncRNA gene trees reflected actual differences in the lineage specificity of expression of the two classes of genes rather than differences in the number or expression levels of protein coding and lncRNA genes. Overall, the clear proximity of early thymic progenitor transcriptomes (Thy1 and Thy2) to HSCs and LMPPs rather than to CLPs suggested that the pre-commitment thymic progenitor cells that gave rise to the T lineage arose directly from BM-derived multipotent HSCs and/ or LMPPs and that the CLP stage marked the launch of a transcriptionally separate program, which largely overlapped that of fully B lineage-committed CD19 + lymphoid progenitor cells.
To further delineate the transcriptional relationships among the earliest BM and thymic progenitor cells, we used Bayesian polytomous model selection, an algorithm that has been used to study transcriptional changes underlying the differentiation of cord blood progenitor cells 25 . This approach enabled us to scrutinize transcriptional proximities between selected early progenitor cell types in a highly stringent statistical context without the influence of transcriptomes of fully lineage-committed populations (BCP, Thy3, Thy4, Thy5 and Thy6). We first performed model selection using both proteincoding genes and lncRNA genes (n = 38,613 genes) (Fig. 5a) . For a given combination of any three cell types, we assigned each gene to the null model (expression similar in all three cell types) or to one of the alternative (non-null) models (expression different in at least one, and possibly all, cell types). The total number of genes classified in nonnull models ('classified genes') for a given combination of samples can be interpreted as an inverse measure of the transcriptional similarity between the cell types in the combination. As predicted, we found
Tree 3: all IncRNA genes (1,182) Tree 4: novel IncRNA genes (377) . We then applied model selection to the least-committed BM cell types (HSC, LMPP and CLP) and thymic cell types (Thy1 and Thy2). Gene-ontology analysis of the genes classified confirmed the ability of this approach to appropriately identify the core transcriptional differences between cell types within a given combination; for example, genes whose expression is associated with T cell differentiation showed significant enrichment (P < 0.05) among the genes expressed uniquely in thymic progenitor cells, relative to their abundance in the genome as a whole (Supplementary Fig. 6 ).
Less than 3% of all genes were classified in non-null models when we studied the earliest progenitor cells (HSC, LMPP, CLP, Thy1 and Thy2) (Fig. 5a) , which demonstrated the close biological similarities of these cell populations and the stringent model-assignment criteria used. However, combinations that included the CLP cell type contained much greater numbers of classified genes than those that did not include this cell type (Fig. 5a and Supplementary Table 9) , which confirmed that the CLP has a transcriptional program distinct from that of uncommitted thymic progenitor cells (Thy1 and Thy2), HSCs and LMPPs. Notably, we found the least number of classified genes for the HSC-LMPP-Thy1 combination (Fig. 5a and Supplementary Table 9 ). The striking similarity of these three cell types suggested close developmental relationships of LMPPs and Thy1 cells with HSCs and that the Thy1 subset was the most primitive progenitor cell population in the human thymus. When we restricted the input set of genes for Bayesian polytomous analysis to only lncRNA genes (n = 18,268 genes), the transcriptional relationships seen between the progenitor cells were recapitulated; differences in lncRNA gene expression were dominated by the presence of CLPs (Fig. 5b and  Supplementary Table 9 ). These data demonstrated that the exquisitely cell type-specific nature of lncRNA expression in BM and thymic progenitor cells could be used to define developmental relationships, independently of the expression of protein-coding genes.
Co-expression modules of lncRNA and coding genes Correlation-based approaches are widely used to infer the function of lncRNAs. These include co-expression analysis (i.e., putative functions of a given lncRNA are inferred on the basis of those of protein-coding genes that show strong co-expression with the lncRNA gene; 'guilt by association'), and functional associations based on the cell type specificity of lncRNAs 26 . Here we used weighted gene-co-expression network analysis (WGCNA), which allows these two strategies to be combined 27 . WGCNA first identifies modules of genes with strong co-expression, from which modules with cell type-specific expression profiles can be easily selected. Additionally, individual genes within these modules can be ranked by module membership (a measure of how similar the expression profile of a gene is to that of the module). Screening for genes with high module membership has been shown to be a useful strategy for the identification of genes of biological interest 28 .
Of the 45 modules identified by WGCNA in our samples, we chose five for further analysis, as they demonstrated significant lineage-or differentiation stage-specific profiles (Fig. 6a,b) : the HSPC module (all CD34 + cells), the B lineage module (CLPs and BCPs), the T lineage module (Thy1-Thy6), the lymphoid module (both B lineage populations (CLPs and BCPs) and T lineage populations (Thy2-Thy4)), and (c) Coding-to-non-coding association, showing candidate lncRNA genes identified on the basis of strong co-expression with protein-coding genes in the HSPC module that belong to the functional annotation 'proto-oncogenes' (includes genes encoding products known to be important for HSPC maintenance) (black circles) and the three most positively correlated (yellow circles, correlation coefficient >0) and negatively correlated (orange circles, correlation coefficient <0) lncRNA genes for each coding gene. (d) Non-coding-to-coding association, showing the ten lncRNA genes with the highest expression (black circles) and the three most positively and negatively correlated (as in c) protein-coding genes for each of those lncRNA genes, among genes with high module membership (adjusted P value, < 0.01).
npg r e s o u r c e the early thymic progenitor module (Thy1-Thy3). These modules contained protein-coding genes known to be specific to each of the cell types, including HSPCs (CD34 and ERG), the B lineage (PAX5 and EBF1), the T lineage (BCL11B and CD3), the lymphoid lineage (RAG1 and RAG2), and early thymic progenitor cells (NOTCH1) 29 , respectively. We then ranked the individual genes in each module on the basis of module membership (Supplementary Table 10 ).
To aid the use of our database as a resource, we provide two examples of how the approach described above can be used to identify candidate lncRNA genes and lncRNA gene-protein-coding gene co-expression associations for further functional studies (Fig. 6c,d) . The first strategy (coding-to-non-coding association; Fig. 6c ) involves the selection, from a module of interest, of protein-coding genes whose products are known to be important in a specific functional process. lncRNA gene candidates are then identified on the basis of how strongly their expression profile correlates with that of the selected protein-coding genes. The second strategy (non-coding-to -coding association; Fig. 6d ) involves the selection of candidate lncRNA genes on the basis of module membership and expression strength (since high expression might facilitate functional characterization). The associated protein-coding genes are then identified on the basis of how strongly their expression profile correlates with that of the selected lncRNA genes. We have tabulated the lncRNA-protein coding gene associations identified when we analyzed the five chosen modules with these two strategies (Supplementary Table 10) . Overall, the WGCNA results provide a searchable resource for the identification of lncRNA candidates and generate hypotheses for functional studies to elucidate the role of lncRNAs in lymphopoiesis.
DISCUSSION
This report represents the first integrated transcriptional map, to our knowledge, of protein-coding and lncRNA elements underlying the initial phases of postnatal lymphoid commitment in the human BM and thymus. An evolutionary study has shown considerable differences between the repertoires of mouse lncRNAs and those of human lncRNAs 30 . Among the few studies of human hematopoiesis, most have analyzed cord blood progenitor cells or fully differentiated peripheral blood lymphocytes 25, 31 , which are functionally and immunophenotypically different from the BM and thymic progenitor cells that underlie steady-state postnatal lymphoid commitment 6 . Furthermore, the conceptual framework of lymphoid development in the BM and thymus is based largely on the lineage potential of isolated progenitor cells assessed by in vitro or xenotransplantation assays. However, the non-physiological nature of these assays creates considerable challenges for the interpretation of such studies of human lymphopoiesis. Thus, in our report here, we examined the relationship between BM progenitor cells and thymic progenitor cells through the use of global gene-expression profile analyses of purified unperturbed cells. Even among these closely related cell types, analysis of global lncRNA expression profiles uncovered new relationships, which suggests an important role for lncRNAs during the initial stages of lymphopoiesis.
Two published studies have annotated lncRNAs in unfractionated thymocytes 17 and in thymic progenitor cells stimulated ex vivo with ligands for the Notch family of receptors 32 . While approximately one fourth of the lncRNAs expressed in thymic progenitor cells in our data set overlapped those reported in the published studies 17, 32 , we identified over 2,000 unique, previously undescribed lncRNA genes in the thymic transcriptome. The use of purified subpopulations of CD34 + progenitor cells (which are extremely rare in whole thymic tissue) in our study, the predominance of leukemic samples in the data sets used for defining lncRNAs in other studies, and the transcriptional changes related to non-physiological conditions in culture might account for the differences in the repertoires of lncRNA genes described in our report here and in previous reports. Our results underscore the importance of defining lncRNAs de novo in unmanipulated purified rare progenitor populations.
The unmapped nature of the lncRNAs that underlie the lymphoid commitment of human cells has represented a substantial obstacle to the delineation of the transcriptional circuits that regulate lymphopoiesis. The database presented here of annotated lncRNAs expressed in the rare progenitor cells that mark the initiation of the divergence of the B lineage and T lineage has allowed us to catalog protein-coding gene-lncRNA gene associations and to identify developmental relationships between these progenitor stages. Thus, we have provided a resource for parsing the lncRNA circuitry in normal lymphopoiesis and for understanding aberrations of these mechanisms in immunodeficiencies and lymphoid malignancies.
METHODS
Methods and any associated references are available in the online version of the paper. 
